Diagnostic Cytogenetics Inc is categorized under Medical Labs in Seattle, WA and active since 1981.
Diagnostic Cytogenetics Inc was established in 1981, and today employs 1 to 4, earning $2.500.000 to $4.999.999 per year. This is a Medical Labs business, which does work in the B2C market, and is classified as a Medical Labs, under code number 6215110 by the NAICS.
If you are seeking more information, feel free to contact Kam Au, Owner at the company’s single location by writing to 1525 13th Avenue, Seattle, Washington WA 98122 or by phoning (206) 328-2026. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Diagnostic Cytogenetics Inc |
| Contact Person: | Kam Au, Owner |
| Address: | 1525 13th Avenue, Seattle, Washington 98122 |
| Phone Number: | (206) 328-2026 |
| Website Address: | diagnosticcytogenetics.com |
| Annual Revenue (USD): | $2.500.000 to $4.999.999 |
| Founded: | 1981 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Medical Labs |
| SIC Code: | 8071 |
| NAICS Code: | 6215110 |
| Share This Business: |
Diagnostic Cytogenetics Inc was started in 1981 to provide professional Medical Labs under the SIC code 8071 and NAICS code 6215110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $2.500.000 to $4.999.999 per annum.
Feel free to contact Kam Au, Owner for inquiries that concern Diagnostic Cytogenetics Inc by calling the company number (206) 328-2026, as your correspondence is most welcome. Additionally, the physical location of the single location of Diagnostic Cytogenetics Inc can be found at the coordinates 47.61493,-122.31561 as well as the street address 1525 13th Avenue in Seattle, Washington 98122.
For its online presence, you may visit Diagnostic Cytogenetics Inc’s website at diagnosticcytogenetics.com and engage with its social media outlets through on Twitter and on Facebook.